PADOVAN, Melissa
 Distribuzione geografica
Continente #
NA - Nord America 6.080
AS - Asia 3.394
EU - Europa 2.515
SA - Sud America 495
AF - Africa 47
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.541
Nazione #
US - Stati Uniti d'America 5.936
SG - Singapore 1.397
CN - Cina 1.029
IT - Italia 763
UA - Ucraina 481
BR - Brasile 408
DE - Germania 370
HK - Hong Kong 331
TR - Turchia 251
GB - Regno Unito 213
VN - Vietnam 166
FR - Francia 145
SE - Svezia 136
FI - Finlandia 135
RU - Federazione Russa 92
CA - Canada 69
MX - Messico 62
IN - India 56
PL - Polonia 49
ID - Indonesia 44
AR - Argentina 38
NL - Olanda 34
JP - Giappone 31
ZA - Sudafrica 28
ES - Italia 22
BD - Bangladesh 20
BE - Belgio 17
LT - Lituania 15
EC - Ecuador 11
IQ - Iraq 10
MY - Malesia 9
CH - Svizzera 8
CO - Colombia 8
PY - Paraguay 8
AT - Austria 7
CL - Cile 7
IE - Irlanda 7
AU - Australia 6
PE - Perù 6
VE - Venezuela 6
KR - Corea 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
MA - Marocco 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BH - Bahrain 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
PK - Pakistan 3
RO - Romania 3
TT - Trinidad e Tobago 3
AP - ???statistics.table.value.countryCode.AP??? 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EU - Europa 2
JM - Giamaica 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
TH - Thailandia 1
Totale 12.541
Città #
Singapore 762
Ashburn 541
Woodbridge 504
Fairfield 489
Jacksonville 424
Chandler 414
Santa Clara 353
Hong Kong 329
Beijing 328
Ann Arbor 273
Houston 234
Seattle 188
Wilmington 176
Cambridge 160
Los Angeles 133
Izmir 130
Nanjing 129
Dallas 108
New York 107
Milan 103
Munich 92
Princeton 88
Ho Chi Minh City 65
Boardman 61
Dearborn 57
Ferrara 57
San Diego 57
Shanghai 51
Rome 47
Shenyang 44
Nanchang 42
Warsaw 42
Mexico City 41
Bremen 39
São Paulo 39
Hanoi 35
Hefei 35
The Dalles 32
Turku 31
Hebei 30
Jakarta 28
Falls Church 27
Tokyo 27
Toronto 26
San Mateo 25
Buffalo 24
Montreal 24
Denver 23
Falkenstein 23
Jinan 23
Stockholm 23
Tianjin 23
Helsinki 22
Jiaxing 22
Moscow 22
Changsha 20
Phoenix 20
Rio de Janeiro 20
Brooklyn 19
San Francisco 19
Atlanta 18
London 18
Redwood City 18
Johannesburg 17
Brussels 16
Chennai 16
Orem 16
Addison 14
Amsterdam 14
Bologna 14
Frankfurt am Main 14
Ankara 13
Boston 13
Chicago 13
Norwalk 13
Verona 13
Davis 12
Manchester 12
Council Bluffs 10
Des Moines 10
Genoa 10
Mountain View 10
Philadelphia 10
Salvador 10
Zhengzhou 10
Florence 9
Guangzhou 9
Kunming 9
Ningbo 9
Ottawa 9
Turin 9
Brasília 8
Kuala Lumpur 8
Orange 8
Redmond 8
Taizhou 8
Bari 7
Cagliari 7
Charlotte 7
Columbus 7
Totale 7.786
Nome #
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 246
La CEFALEA NEL LUPUS ERITEMATOSO SISTEMICO 245
IPEROSTOSI SCHELETRICA IDIOPATICA DIFFUSA (D.I.S.H.). 237
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 223
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 218
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 215
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 208
Prevalenza degli anticorpi anti-citrullina (CCP) nell’artrite reumatoide (A.R.): confronto con pazienti affetti da malattia di Still dell’Adulto. Studio preliminare 197
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound 192
The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate 191
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 185
ANTI-CITRULLINA ANTIBODIES IN ADULT ONSET STILL DISEASE. PRELIMINARY RESULTS 182
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center 181
Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature 179
Il neuroimaging funzionale nella valutazione del coinvolgimento neurologico in corso di lupus eritematoso sistemico. Risultati preliminari [The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results] 177
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 173
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study 168
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 161
The c.1298A>C polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) gene is risk factor for Rheumatoid Arthritis 159
Does early arthritis clinic organization improve outcomes? What evidence is there? A systematic review. 153
The role of adenosine receptors in rheumatoid arthritis. 153
Ischemia cerebrale focale occipitale in corso di lupus eritematoso sistemico. Ruolo del neuroimaging funzionale nel riconoscimento di lesioni acute in fase precoce 152
La medicina nucleare in reumatologia: un valido strumento diagnostico e terapeutico 151
CNS involvement in primary Sjögren's syndrome: Prevalence, clinical aspects, diagnostic assessment and therapeutic approach 148
NEURAL SLE: THE ROLE OF IMAGING IN EARLY DIAGNOSIS 148
Artrosi lombare e sindrome D.I.S.H. 147
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 147
Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study 147
Pregnancy in undifferentiated connective tissue disease patients: a prospective case-control study 140
Interessamento del sistema nervoso nella sindrome di Sjogren primaria. 139
Gli splint per la mano reumatoide: valutazione dell'efficacia e delle compliance 131
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis. 128
Percezione dello stato di salute in pazienti affetti da Lupus eritematoso sistemico. Studio di 159 pazienti con e senza interessamento neurologico 125
Efficacia e compliance dello splint funzionale per il polso in pazienti con artrite reumatoide 123
Safety of abatacept in rheumatoid arthritis with serological evidence of past or present hepatitis B virus infection 123
MENINGIOMA AND SYSTEMIC LUPUS ERYTHEMATOSUS: A PURE COINCIDENCE? 122
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 122
null 121
Tumor necrosis factor receptor II gene polymorphism influences outcome of anti-TNF therapy in rheumatoid arthritis 121
Trapianto autologo di cellule staminali in paziente affetta da sclerosi sistemica a varietà diffusa. 120
I farmaci impiegati nella terapia del LES 116
Iperostosi scheletrica diffusa (DISH) 116
null 112
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry 111
The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients 111
β Thalassaemic trait and systemic lupus erythematosus 110
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 110
Improved pregnancy outcome in patients with Rheumatoid Arthritis who followed an ideal clinical pathway 109
La qualità di vita nelle malattie reumatiche. Le misure in Reumatologia. 106
Efficacia e tollerabilità dell’associazione leflunomide - anti-TNFalfa nel trattamento dell’artrite reumatoide 106
Association between MTHFR C.1298A > C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis 106
Late onset systemic lupus erythematosus. No substantial differences using different cut-off ages. 106
null 104
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 104
The use of uterine artery doppler as a predictive tool for adverse gestational outcomes in pregnant patients with autoimmune and thrombophilic disease. 98
Can HLA-G predict disease course in rheumatoid arthritis patients? 97
null 96
null 96
Beta-thalassemia e lupus eritematoso sistemico 96
Il neuroimaging funzionale nella valutazione del coinvolgimento neurologico in corso di LES. Risultati preliminari”. 95
null 94
TRATTAMENTO FARMACOLOGICO (DELLA SINDROME FIBROMIALGICA) 93
Artropatie microcristalli e dismetaboliche e altre entità nosologiche 93
null 92
null 92
null 92
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. 92
Adenosine and adenosine receptors in rheumatoid arthritis 92
null 91
L'interessamento renale nella sindrome di Sjogren 91
Neuroimaging approach to neurologic involvement in the pathology of systemic autoimmunity of rheumatologic relevance 91
L’image radiologique dans la dèfinition de la “Early-arthritis” 90
null 88
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus:experience from a tertiary referral centre. 88
Extranodal localization of non-Hodgkin’s lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature 87
Studio dei fattori di rischio per il coinvolgimento neurologico in corso di lupus eritematoso sistemico 86
La semeiotica della "early arthritis"[ Semeiology of "early arthritis"] 85
null 84
null 83
Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus 82
Single-photon-emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement. 80
La terapia combinata con farmaci biologici: una nuova frontiera? 79
Introduzione al tema “Imaging in reumatologia: la diagnosi precoce delle forme infiammatorie 79
null 78
Prospettive nel trattamento delle malattie reumatiche. Trends in the treatment of rheumatic diseases. 77
Scleroderma as paraneoplastic disease: A new case of a rare association with renal cell carcinoma 74
Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not metotrexate 74
Gestione del paziente in trattamento con biologici 74
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 74
null 73
Gestione del paziente in trattamento con biologici 73
Health status perception in patients with systemic lupus erythematosus. A study of 159 Italian patients with and without neurological involvement 72
null 66
Neuropsychiatric systemic lupus erythematosus: where are we now? 66
La terapia farmacologica della sindrome fibromialgica primaria 62
Utilità della RMN nella valutazione dell’artrite reumatoide iniziale. 62
La malattia di Still dell’adulto 60
La relazione di dimissione ospedaliera del malato affetto da artrite reumatoide 57
The treatment of the rheumatological manifestations of the inflammatory bowel diseases. 56
Totale 12.020
Categoria #
all - tutte 57.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.549
Totale 61.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021687 0 0 0 0 0 99 38 114 36 159 160 81
2021/2022970 48 111 84 77 54 37 34 54 27 78 90 276
2022/2023980 99 63 31 130 176 137 54 81 124 8 46 31
2023/2024538 45 70 19 26 31 62 19 42 20 35 22 147
2024/20252.315 67 71 173 106 287 218 43 115 433 247 312 243
2025/20263.294 597 221 531 809 960 176 0 0 0 0 0 0
Totale 12.676